Tavokinogene Telseplasmid (tavo)
Sponsors
OncoSec Medical Incorporated
Conditions
Cutaneous T Cell Lymphomas (CTCL)Head and Neck Squamous Cell CarcinomaMelanomaMerkel Cell CarcinomaMycosis Fungoides (MF)
Phase 2
IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer
CompletedNCT01440816
Start: 2012-01-03End: 2015-04-10Updated: 2023-05-15
Trial of pIL-12 Electroporation Malignant Melanoma
CompletedNCT01502293
Start: 2012-02-14End: 2016-03-21Updated: 2023-05-15
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
TerminatedNCT01579318
Start: 2012-06-08End: 2014-06-03Updated: 2023-05-15
Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)
TerminatedNCT02345330
Start: 2015-05-21End: 2016-11-14Updated: 2023-05-15